(NASDAQ: ALEC) Alector's forecast annual revenue growth rate of 13.52% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.64%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.1%.
Alector's revenue in 2024 is $97,062,000.On average, 3 Wall Street analysts forecast ALEC's revenue for 2024 to be $6,088,312,383, with the lowest ALEC revenue forecast at $5,817,724,977, and the highest ALEC revenue forecast at $6,223,701,835. On average, 4 Wall Street analysts forecast ALEC's revenue for 2025 to be $6,668,935,889, with the lowest ALEC revenue forecast at $4,101,898,256, and the highest ALEC revenue forecast at $9,574,925,900.
In 2026, ALEC is forecast to generate $18,357,047,935 in revenue, with the lowest revenue forecast at $18,357,047,935 and the highest revenue forecast at $18,357,047,935.